January - March 2003 articles archive home
Rareco now wants to do something else?
Rareco’s interim report to 31 December 2002 is disconcerting. Two years ago the company reported there were no earnings for the 6 months to December 2000 because it was waiting for a court decision on an application brought by a minority shareholder - three years earlier - to have it wound up.
Monday, March 31, 2003 ... more
 
 
How do investors justify these prices?
Here's a question for fundamental investors: Assuming two companies listed in the same sector of the JSE reported the following figures at year-end, which one would have been trading at 110c and which at 11c on March 20, 2003?
Friday, March 28, 2003 ... more
 
Before you pooh-pooh the trader
More often than not, if you admit to a long-term investor that you trade the market they’ll sneer and say something patronising. Why is that?
Thursday, March 27, 2003 ... more
 
 
Is it wise to follow these directors?
Among the directors who have been buying recently: Anthony Cotterell has purchased more than 10-million shares in Kingco since October 2001; Ian Hewitt and Max Kretzmer each purchased 10-million shares in Lyons.
Wednesday, March 26, 2003 ... more
 
Mouldmed issues a caution, who cares?
Charlatan n, someone who professes expertise, especially in medicine, that he does not have, quack …from ciarlare to chatter – Collins Concise
Tuesday, March 25, 2003 ... more
 
 
Shareholders wait on Gandalf
The Gandalf Trust took control of Acuity last year, promising to refocus operations, find new opportunities and unlock shareholder value. So far so good, latest results confirm cost cutting and disposal of loss reporters stopped losses.
Monday, March 24, 2003 ... more
 
OTR goes from partner to servant Thursday, March 20, 2003
Not for everyone Wednesday, March 19, 2003
Who do they thing they're kidding? Tuesday, March 18, 2003
disclaimer
Michel Pireu & Associates cc, the owners of this website, are active stockmarket traders. The company disclaims all liability for any loss, damage, injury or expense however caused, arising from the use of, or reliance upon, in any manner, the information provided through this service and does not warrant the truth, accuracy or completeness of the information provided. The company's permission is required to reproduce the contents in any form including, capture into a database, website, intranet or extranet.